Analysis Redx Pharma Plc (REDX)
5/31/2024
Analysis of Redx Pharma Plc (REDX)
Redx Pharma Plc is showing some interesting price movements and technical indicators based on the provided data:1. Price Movement:
- The price has been fluctuating between a high of 33.00 and a low of 7.60 over the past few days, indicating high volatility.
- The closing price has ranged from 9.00 to 15.00, with some significant price changes.
2. Relative Strength Index (RSI):
- The RSI values have been fluctuating between 39.79 and 71.11, indicating some level of overbought and oversold conditions.
- The RSI values suggest that the stock has experienced both bullish and bearish momentum recently.
3. Moving Average Convergence Divergence (MACD):
- The MACD indicator has been negative, indicating a bearish trend in the stock price.
- The MACD histogram has shown some positive values, suggesting a potential reversal in the bearish trend.
4. Moving Averages (MA):
- The Simple Moving Average (SMA), Exponential Moving Average (EMA), and Weighted Moving Average (WMA) have been calculated, providing different perspectives on the stock's price trend.
Overall, Redx Pharma Plc appears to be experiencing high volatility with mixed signals from the technical indicators. Traders and investors may need to closely monitor the stock for potential trading opportunities based on their risk tolerance and investment strategy.
Income statement 💸
These are the revenues. Here are the conclusions:1. The company's sales revenue has been increasing steadily over the years, from $274.5 billion in 2020 to $383.3 billion in 2023.
2. Despite fluctuations in other financial metrics, such as net income and EBIT, the trend in revenue growth has been positive.
3. The company seems to be effectively generating sales and increasing its top-line performance, which is a good sign for its overall financial health.
4. It would be beneficial to further analyze the company's cost structure and profitability margins to understand how efficiently it is converting its revenues into profits.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The quarter before that, ending on January 31, 2025, had results released after hours. The results for the quarter ending on October 31, 2024, were not provided at the time. However, for the quarter ending on August 1, 2024, the company had an EPS estimate of 1.32.Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.In terms of financials, the company has strong operating cash flow and levered free cash flow, with a positive current ratio and a high total debt to equity ratio. The profit margin and operating margin are also healthy, indicating efficient operations. The company's fiscal year ends in September 2023, and the most recent quarter reported is March 2024. The company shows good returns on assets and equity.
Looking at stock statistics, the company has a low short ratio and a significant percentage held by institutions. The stock has a beta of 1.264 and has been trading within a range between a fifty-two-week low and high.
Valuation metrics show a relatively high PEG ratio and forward PE ratio. The company's market capitalization and enterprise value are substantial, with a high price to book and price to sales ratios. The enterprise value to EBITDA and revenue ratios are also notable.
The stock price summary includes moving averages, fifty-two-week range, and beta information.
Lastly, dividends and splits data show dividend rates, yield, payout ratio, and historical split information for the company.
Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets include cash, inventory, and receivables, with a significant portion in cash equivalents and short-term investments.
3. Non-current assets consist mainly of investments and advances, along with machinery, furniture, and equipment.
4. Total liabilities have also been increasing, but at a slower pace compared to assets, resulting in a growth in shareholders' equity.
5. Shareholders' equity includes common stock, retained earnings, and other equity components.
6. The company has been managing its short-term and long-term debts while investing in non-current assets for future growth.
7. The accumulated depreciation indicates the wear and tear on the company's assets over the years.
8. The provision for risks and charges has been relatively stable across the years.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value recorded in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show a pattern of common stock repurchase, issuance of long-term debt, and payment of dividends.
6. Investing activities include the sale and purchase of investments, as well as capital expenditures.
7. Overall, the company seems to be managing its cash flow effectively, with a focus on operational efficiency and strategic investments.
Earnings estimate
Based on the analysts' estimates for future quarterly and annual earnings per share:1. For the current quarter ending on June 30, 2024, the average estimated EPS is $1.33, compared to $1.26 a year ago.
2. For the next quarter ending on September 30, 2024, the average estimated EPS is $1.53, compared to $1.46 a year ago.
3. For the current fiscal year ending on September 30, 2024, the average estimated EPS is $6.59, compared to $6.13 a year ago.
4. For the next fiscal year ending on September 30, 2025, the average estimated EPS is $7.23, compared to $6.59 a year ago.
Overall, the analysts are forecasting an increase in earnings per share for both the upcoming quarters and the next fiscal years, indicating positive growth expectations for the company.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average sales estimate is $83,776,900,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 24.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $92,375,300,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 24.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $386,681,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 37.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $411,555,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 37.
These estimates suggest a moderate growth trend in both quarterly and annual sales for the company, with slightly higher growth expected in the next fiscal year compared to the current one.
Growth estimates
Based on the consensus estimates provided:- The company is expected to experience a growth rate of 7.5% in the current year and 9.7% in the next year.
- For the current quarter, the growth rate is estimated to be 5.6%, while for the next quarter it is projected to be 4.8%.
- Over the next 5 years, the company is expected to achieve an average annual growth rate of 11%.
- However, when looking at the past 5 years, the company has actually achieved a higher average annual growth rate of 20.1%.
Overall, it appears that the company is expected to maintain a solid growth trajectory in the coming years, although at a slightly lower rate compared to the past 5 years.
Price target
Based on the analysts' forecast, the future price of the security is expected to range between $164 (low) and $250 (high), with a median estimate of $200 and an average estimate of $202.26. The current price of the security is $191.57.MACD of REDX
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
